Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 420
6
Diseases
77
Unique genes
0.040
Avg. similarity score
Congenital anomalies of the kidney and urinary tract
Most-connected disease (4 links)
Disease
Searched: Neurodevelopmental disorder with or without urinary tract abnormalities
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Neurodevelopmental disorder with or without urinary tract abnormalities
Congenital anomalies of the kidney and urinary tract
Renal agenesis
Renal dysplasia, cystic, susceptibility to
Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome
Renal hypodysplasia/aplasia 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital anomalies of the kidney and urinary tract | 4 | 4 | 67 |
| Renal agenesis | 3 | 3 | 16 |
| Renal dysplasia, cystic, susceptibility to | 2 | 2 | 1 |
| Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome | 1 | 1 | 1 |
| Neurodevelopmental disorder with or without urinary tract abnormalities | 1 | 1 | 1 |
| Renal hypodysplasia/aplasia 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BICC1 | 3 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis, Renal dysplasia, cystic, susceptibility to |
| CELSR3 | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Neurodevelopmental disorder with or without urinary tract abnormalities |
| CTU2 | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome |
| FGF20 | 2 / 6 | Renal agenesis, Renal hypodysplasia/aplasia 2 |
| FRAS1 | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis |
| GREB1L | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis |
| RET | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis |
| ROBO1 | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis |
| TBX18 | 2 / 6 | Congenital anomalies of the kidney and urinary tract, Renal agenesis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ECM-receptor interaction | KEGG | 6 / 89 | 10.5× | 2.17e-5 | 4.95e-4 ✓ sig. |
| Signaling by ROBO receptors | Reactome | 3 / 12 | 39.0× | 5.35e-5 | 1.04e-3 ✓ sig. |
| Regulation of commissural axon pathfinding by SLIT and ROBO | Reactome | 2 / 3 | 104× | 1.21e-4 | 2.00e-3 ✓ sig. |
| Metabolism of Angiotensinogen to Angiotensins | Reactome | 3 / 17 | 27.5× | 1.62e-4 | 2.52e-3 ✓ sig. |
| Role of ABL in ROBO-SLIT signaling | Reactome | 2 / 4 | 78.0× | 2.41e-4 | 3.49e-3 ✓ sig. |
| SLIT2:ROBO1 increases RHOA activity | Reactome | 2 / 4 | 78.0× | 2.41e-4 | 3.49e-3 ✓ sig. |
| Renin-angiotensin system | KEGG | 3 / 23 | 20.3× | 4.09e-4 | 5.29e-3 ✓ sig. |
| Hippo signaling pathway | KEGG | 6 / 157 | 6.0× | 5.00e-4 | 6.19e-3 ✓ sig. |
| Regulation of expression of SLITs and ROBOs | Reactome | 2 / 8 | 39.0× | 1.11e-3 | 1.14e-2 ✓ sig. |
| Axon guidance | KEGG | 6 / 183 | 5.1× | 1.12e-3 | 1.15e-2 ✓ sig. |
| Molecules associated with elastic fibres | Reactome | 3 / 38 | 12.3× | 1.82e-3 | 1.66e-2 ✓ sig. |
| FGFR1c ligand binding and activation | Reactome | 2 / 12 | 26.0× | 2.57e-3 | 2.15e-2 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 4 / 99 | 6.3× | 3.71e-3 | 2.79e-2 ✓ sig. |
| Renin secretion | KEGG | 3 / 69 | 6.8× | 9.80e-3 | 5.38e-2 |
| Negative regulation of FGFR1 signaling | Reactome | 2 / 26 | 12.0× | 1.19e-2 | 6.06e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| kidney development | GO:0001822 | 18 / 146 | 29.9× | 4.43e-22 | 8.60e-19 ✓ sig. |
| ureteric bud development | GO:0001657 | 9 / 41 | 53.3× | 6.66e-14 | 3.68e-11 ✓ sig. |
| metanephros development | GO:0001656 | 8 / 38 | 51.1× | 2.53e-12 | 1.02e-9 ✓ sig. |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 8 / 45 | 43.1× | 1.09e-11 | 3.86e-9 ✓ sig. |
| pulmonary valve morphogenesis | GO:0003184 | 6 / 18 | 80.9× | 7.16e-11 | 2.10e-8 ✓ sig. |
| nephric duct formation | GO:0072179 | 4 / 4 | 243× | 2.66e-10 | 6.74e-8 ✓ sig. |
| mesonephros development | GO:0001823 | 5 / 13 | 93.3× | 1.31e-9 | 2.73e-7 ✓ sig. |
| aortic valve morphogenesis | GO:0003180 | 6 / 37 | 39.4× | 8.43e-9 | 1.41e-6 ✓ sig. |
| mesodermal cell fate specification | GO:0007501 | 4 / 7 | 139× | 9.24e-9 | 1.53e-6 ✓ sig. |
| anatomical structure morphogenesis | GO:0009653 | 9 / 160 | 13.7× | 1.94e-8 | 2.94e-6 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 20 / 1,208 | 4.0× | 5.91e-8 | 7.60e-6 ✓ sig. |
| ureter maturation | GO:0035799 | 3 / 4 | 182× | 2.68e-7 | 2.70e-5 ✓ sig. |
| maintenance of blood vessel diameter homeostasis by renin-angiotensin | GO:0002034 | 3 / 5 | 146× | 6.69e-7 | 5.77e-5 ✓ sig. |
| cell fate determination | GO:0001709 | 4 / 18 | 53.9× | 7.80e-7 | 6.55e-5 ✓ sig. |
| smooth muscle cell differentiation | GO:0051145 | 4 / 18 | 53.9× | 7.80e-7 | 6.55e-5 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Congenital anomalies of the kidney and urinary tract | Renal agenesis | 0.077 | 6 | 4.03e-11 | 3.90e-10 ✓ sig. |
| Renal agenesis | Renal dysplasia, cystic, susceptibility to | 0.059 | 1 | 1.03e-3 | 1.57e-3 ✓ sig. |
| Renal agenesis | Renal hypodysplasia/aplasia 2 | 0.059 | 1 | 1.03e-3 | 1.57e-3 ✓ sig. |
| Congenital anomalies of the kidney and urinary tract | Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome | 0.015 | 1 | 4.33e-3 | 5.28e-3 ✓ sig. |
| Congenital anomalies of the kidney and urinary tract | Neurodevelopmental disorder with or without urinary tract abnormalities | 0.015 | 1 | 4.33e-3 | 5.28e-3 ✓ sig. |
| Congenital anomalies of the kidney and urinary tract | Renal dysplasia, cystic, susceptibility to | 0.015 | 1 | 4.33e-3 | 5.28e-3 ✓ sig. |